Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

Biosciences and Emerging Technology

NINTH MEETING

2007-2008 Regular Session - February 07, 2007

STATE OF MINNESOTA NINTH MEETING
HOUSE OF REPRESENTATIVES EIGHTY-FIFTH SESSION

BIOSCIENCES AND EMERGING TECHNOLOGIES COMMITTEE

MINUTES


Representative Tim Mahoney, Chair of the Committee, called the meeting to order at 10:05AM on February 7, 2007 in Room 200 of the State Office Building.

The Committee Legislative Assistant noted the roll.

Members present:

MAHONEY, Tim (Chair)
NORTON, Kim (Vice Chair)
BEARD, Michael
BERNS, John
BUNN, Julie
HAWS, Larry
MASIN, Sandra
PEPPIN, Joyce
RUTH, Connie
THISSEN, Paul
WINKLER, Ryan

A quorum was present.

Representative Berns moved that the minutes from February 6, 2007 be adopted. THE MOTION PREVAILED.

Vice Chair Norton assumed the gavel at 10:07AM.

HF 290 (Mahoney), a bill for an act relating to economic development; appropriating money to the commissioner of employment and economic development for University Enterprise Laboratories, Inc.

Representative Mahoney moved that HF 290 be recommended to pass and be re-referred to the Committee on Finance.

Testifying in support of the bill:

Robert Elde, Chairman of the Board, University Enterprise Laboratories
Randy Olson, General Manager, University Enterprise Laboratories
Phil Messina, Chief Operating Officer, Gel-Del Technologies

Biosciences and Emerging Technologies
February 7, 2007
Page 2


Representative Mahoney moved amendment H0290A1 (attached).

THE MOTION PREVAILED. THE AMENDMENT WAS ADOPTED. Questions and discussion followed.

Representative Mahoney renewed his motion that HF 290, as amended, be recommended to pass and be re-referred the Committee on Finance. THE MOTION PREVAILED.

Chair Mahoney assumed the gavel at 10:36AM.

HF 34 (Kahn), a bill for an act relating to health; establishing state policy for stem cell research; providing criminal penalties; appropriating money;

Chair Mahoney moved that HF 34 be reported to the House without recommendation and be re-referred to the Higher Education and Work Force Development Policy and Finance Division.

Chair Mahoney moved amendment A07-0033 (attached). Discussion and questions followed.

THE MOTION PREVAILED. THE AMENDMENT WAS ADOPTED.

Chair Mahoney moved amendment A07-0034 (attached).

THE MOTION PREVAILED. THE AMENDMENT WAS ADOPTED.

Testifying in support of the bill:

Phyllis Kahn, State Representative, Minnesota House of Representatives
Meri Firpo, Ph.D., Assistant Professor, University of Minnesota
Jackie Hunt Christensen, State Coordinator, Parkinson Action Network
Linda Sandvig, LifeScience Alley

Testifying in opposition to the bill:

Chris Leifeld, Executive Director, Minnesota Catholic Conference
Tom Prichard, President, Minnesota Family Council
Kirk Allison, Ph.D., M.S., Program in Human Rights and Health Director,
School of Public Health, University of Minnesota
Jenny Hoelscher, Legislative Associate, Minnesota Citizens Concerned for Life
Andrea Rau, Legislative Associate, Minnesota Citizens Concerned for Life

Representative Peppin moved amendment A07-0032 (attached).

Biosciences and Emerging Technologies
February 7, 2007
Page 3



Representative Peppin offered an oral amendment as follows:

Line 1.2, strike

Line 1.3, strike

Line 1.11 through 1.13, strike

The oral amendment was incorporated into amendment A07-0032.

THE MOTION DID NOT PREVAIL. THE AMENDMENT WAS NOT ADOPTED.

Representative Peppin moved amendment A07-0030 (attached).

THE MOTION DID NOT PREVAIL. THE AMENDMENT WAS NOT ADOPTED.

Chair Mahoney renewed his motion that HF 34, as amended, be re-referred without recommendation to the Higher Education and Work Force Development Policy and Finance Division. THE MOTION PREVAILED.

The meeting was adjourned at 11:58AM.


Rep. Tim Mahoney, Chair


Autumn Williams-Wussow,
Committee Legislative Assistant
More Info On This Meeting..

HF290 (Mahoney) University Enterprise Laboratories Inc., funding provided for bioscience business development.
HF34 (Kahn) Stem cell research state policy established authorizing the University of Minnesota to spend state-appropriated funds on stem cell research.